2-氧代-PCE

化合物
(重定向自2-Oxo-PCE

2-氧代-PCE(2-Oxo-PCE),或N-ethyldeschloroketamineeticyclidoneO-PCE,是一种芳基环己胺解离麻醉剂,与去氯恺他命英语Deschloroketamine乙环利定关系密切,曾被制成策划药于网上销售。[4][5][6][7][8][9][10][11]

2-氧代-PCE
法律规范状态
法律规范
识别信息
  • 2-(ethylamino)-2-phenyl-cyclohexanone
CAS号6740-82-5  checkY
4551-92-2  checkY
PubChem CID
ChemSpider
UNII
化学信息
化学式C14H19NO
摩尔质量217.31 g·mol−1
3D模型(JSmol英语JSmol
  • CCNC1(CCCCC1=O)C2=CC=CC=C2
  • InChI=1S/C14H19NO/c1-2-15-14(11-7-6-10-13(14)16)12-8-4-3-5-9-12/h3-5,8-9,15H,2,6-7,10-11H2,1H3
  • Key:IDLSBAANXISGEI-UHFFFAOYSA-N

参考文献

编辑
  1. ^ Controlled Drugs and Substances Act (S.C. 1996, c. 19) - SCHEDULE I. Government of Canada - Justice Laws Website. [15 July 2020]. (原始内容存档于2023-06-04). 
  2. ^ Cheng WC, Dao KL. The Emergence of Deschloro-N-ethyl-ketamine, a Ketamine Analog, in Drug Seizures and Drug Driving Cases in Hong Kong. Journal of Analytical Toxicology. April 2020, 44 (8): 886–895. PMID 32364605. doi:10.1093/jat/bkaa038 . 
  3. ^ Fjorton nya ämnen klassas som narkotika eller hälsofarlig vara. Folkhälsomyndigheten. 12 November 2018 [2023-10-01]. (原始内容存档于2021-01-20) (瑞典语). 
  4. ^ deschloro-N-ethyl-Ketamine (hydrochloride) (CAS 4551-92-2). www.caymanchem.com. [2023-10-01]. (原始内容存档于2023-07-09). 
  5. ^ Jason W, Brandt SD. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances. Handbook of Experimental Pharmacology 252. Springer International Publishing. September 2018: 305–352. ISBN 978-3-030-10561-7. PMID 30196446. doi:10.1007/164_2018_148 –通过Springer Link. 
  6. ^ Chong YK, Tang MH, Chan CL, Li YK, Ching CK, Mak TW. 2-oxo-PCE: ketamine analogue on the streets. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi. December 2017, 23 (6): 665–6. PMID 29226843. doi:10.12809/hkmj177089 . 
  7. ^ Tang MH, Chong YK, Chan CY, Ching CK, Lai CK, Li YK, Mak TW. Cluster of acute poisonings associated with an emerging ketamine analogue, 2-oxo-PCE. Forensic Science International. September 2018, 290: 238–243. PMID 30081327. S2CID 207558276. doi:10.1016/j.forsciint.2018.07.014. 
  8. ^ Tang MH, Hung LY, Lai CK, Ching CK, Mak TW. 9-year review of new psychoactive substance use in Hong Kong: A clinical laboratory perspective. Hong Kong Journal of Emergency Medicine. September 2018, 26 (3): 179–185. ISSN 1024-9079. doi:10.1177/1024907918798553 . 
  9. ^ Li C, Lai CK, Tang MH, Chan CC, Chong YK, Mak TW. Ketamine analogues multiplying in Hong Kong. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi. April 2019, 25 (2): 169. PMID 30971512. doi:10.12809/hkmj197863 . 
  10. ^ Theofel N, Möller P, Vejmelka E, Kastner K, Roscher S, Scholtis S, Tsokos M. A Fatal Case Involving N-Ethyldeschloroketamine (2-Oxo-PCE) and Venlafaxine. Journal of Analytical Toxicology. March 2019, 43 (2): e2–e6. PMID 30365028. doi:10.1093/jat/bky063. 
  11. ^ Tamama K, Lynch MJ. Newly Emerging Drugs of Abuse. Substance Use Disorders. Handbook of Experimental Pharmacology 258. October 2019: 463–502. ISBN 978-3-030-33678-3. PMID 31595417. S2CID 203983418. doi:10.1007/164_2019_260.